Loading
Latest filing published 01 Mar 2011 for MARTEK BIOSCIENCES CORP.
No signal scores available.
This profile gathers the share dealings of David Feitel in Martek Biosciences Corp. The record holds 10 filings, for trades running from 19 March 2008 to 25 February 2011.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 1 March 2011: a share grant, in Martek Biosciences Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations